AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9071861 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 320
Study 8384187 — intervention group
Group type: EXPERIMENTAL
Intervention: ECA (ephedrine 75‐150mg, caffeine 150mg, aspirin 330mg)
Number of subjects: 24
Study 8384187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 3519551 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-a-week radiation therapy (1 X W) - 6000 rad using 500 rad fractions for 12 weeks
Number of subjects: 100
Study 3519551 — intervention group
Group type: COMPARATOR
Intervention: Daily radiation therapy (5 X W) - 6000 rad using 200 rad fractions for 6 weeks
Number of subjects: 100
Study 30885221 — intervention group
Group type: EXPERIMENTAL
Intervention: Armolipid Plus (AP) - 500 mg berberine, 3 mg monacolin K, 10 mg policosanol, once daily for 24 weeks
Number of subjects: 158
Study 30885221 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL) - once daily for 24 weeks
Number of subjects: 158
Study 30141444 — intervention group
Group type: EXPERIMENTAL
Intervention: 200μg of intravaginal misoprostol every 6 hours for up to 48 hours
Number of subjects: 30
Study 26952037 — intervention group
Group type: EXPERIMENTAL
Intervention: BOW015
Number of subjects: 84
Study 26952037 — intervention group
Group type: COMPARATOR
Intervention: rIFX
Number of subjects: 84
Study 25161155 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg empagliflozin
Number of subjects: 53
Study 25161155 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg simvastatin
Number of subjects: 53
Study 25161155 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg empagliflozin with 40 mg simvastatin
Number of subjects: 53
Study 25161155 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 53
Study 22935476 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years teacher classroom management (TCM) course
Number of subjects: 80
Study 22935476 — intervention group
Group type: COMPARATOR
Intervention: Teach as normal (control arm)
Number of subjects: 80
Study 20445470 — intervention group
Group type: EXPERIMENTAL
Intervention: OP-1 combined with locally available bone from laminectomy
Number of subjects: 36
Study 20445470 — intervention group
Group type: COMPARATOR
Intervention: Iliac crest autograft
Number of subjects: 36
Study 17917927 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0
Study 17917927 — intervention group
Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 0
Study 16123873 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan pads (Chito‐Seal, Abbott Vascular Devices)
Number of subjects: 80
Study 14607714 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture therapy (EAT) in combination with liver artery intubation chemotherapy (Group A)
Number of subjects: 106
Study 14607714 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture therapy (EAT) alone (Group B)
Number of subjects: 106
Study 14607714 — intervention group
Group type: COMPARATOR
Intervention: Liver artery intubation chemotherapy alone (Group C)
Number of subjects: 106
Study 10025904 — intervention group
Group type: EXPERIMENTAL
Intervention: Malignant plasma cells from bone marrow and peripheral blood
Number of subjects: 0
Study 10025904 — intervention group
Group type: EXPERIMENTAL
Intervention: Myeloma cells from extramedullary sites (pleural effusion, ascitis, mammary and gastric plasmacytoma)
Number of subjects: 0
Study 10025904 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal non-dividing bone marrow plasma cells
Number of subjects: 0
Study 10025904 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly proliferative reactive plasmacytosis
Number of subjects: 0
Study 7744151 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyridoxine administration
Number of subjects: 291
Study 7744151 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 291
Study 2282207 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplement
Number of subjects: 18
Study 2282207 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 18
Study 2282207 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal pregnancies)
Number of subjects: 18
Study 6786067 — intervention group
Group type: EXPERIMENTAL
Intervention: diltiazem (120 mg/day)
Number of subjects: 12
Study 6786067 — intervention group
Group type: EXPERIMENTAL
Intervention: diltiazem (240 mg/day)
Number of subjects: 12
Study 6786067 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study 6786067 — intervention group
Group type: COMPARATOR
Intervention: placebo following diltiazem
Number of subjects: 12
Study 6786067 — intervention group
Group type: EXPERIMENTAL
Intervention: diltiazem
Number of subjects: 12
Study 31714452 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training with blood flow restriction (ST-BFR)
Number of subjects: 18
Study 31714452 — intervention group
Group type: COMPARATOR
Intervention: Multiple-set training at 30% of 1RM
Number of subjects: 18
Study 31714452 — intervention group
Group type: COMPARATOR
Intervention: Multiple-set training at 75% of 1RM
Number of subjects: 18
Study 30626095 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-day protein restricted diet (0.25 g protein/kg body weight/day)
Number of subjects: 16
Study 30626095 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet (1.3 ± 0.3 g protein/kg body weight/day)
Number of subjects: 16
Study 30626095 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein restricted diet
Number of subjects: 16
Study 30626095 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet
Number of subjects: 16
Study 28240340 — intervention group
Group type: EXPERIMENTAL
Intervention: ADAPT (adaptation programme)
Number of subjects: 85
Study 28240340 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTIVE (physical activity programme)
Number of subjects: 85
Study 25391549 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocodone ER tablet with low-level coating
Number of subjects: 0
Study 25391549 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocodone ER tablet with intermediate-level coating
Number of subjects: 0
Study 25391549 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocodone ER tablet with high-level coating
Number of subjects: 0
Study 25391549 — intervention group
Group type: COMPARATOR
Intervention: Hydrocodone IR/acetaminophen (APAP) 10/325 mg
Number of subjects: 0
Study 23832726 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist group (Group A) - r‐FSH (50‐75 IU/d) plus cetrorelix (0.25 mg/d) starting when ≥ 2 follicles ≥ 14 mm were detected on ultrasound scan.
Number of subjects: 80
Study 23832726 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B) - r‐FSH (50‐75 IU/d) only.
Number of subjects: 80
Study 23832726 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist group (Group A)
Number of subjects: 80
Study 23832726 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 80
Study 23832726 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 20942865 — intervention group
Group type: EXPERIMENTAL
Intervention: MPT (melphalan 9 mg/m²/d for 4 days every 6 weeks, prednisone 60 mg/m²/d for 4 days every 6 weeks, thalidomide 100 mg/d continuously)
Number of subjects: 122
Study 20942865 — intervention group
Group type: COMPARATOR
Intervention: MP (melphalan 9 mg/m²/d for 4 days every 6 weeks, prednisone 60 mg/m²/d for 4 days every 6 weeks)
Number of subjects: 122
Study 20942865 — intervention group
Group type: EXPERIMENTAL
Intervention: MPT
Number of subjects: 122
Study 20942865 — intervention group
Group type: COMPARATOR
Intervention: MP
Number of subjects: 122
Study 20942865 — intervention group
Group type: EXPERIMENTAL
Intervention: MPT and MP
Number of subjects: 122
Study 19604191 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T(3)) replacement therapy, 20 microg every 12 h starting just before induction of anaesthesia until the first day after surgery
Number of subjects: 50
Study 19604191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 19604191 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral triiodothyronine (T(3)) replacement therapy
Number of subjects: 50
Study 18647466 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin quantitation method using high-performance liquid chromatography coupled to electrospray mass spectrometry
Number of subjects: 0
Study 16262513 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment for delinquency and alcohol and/or marijuana use disorders
Number of subjects: 80
Study 11848168 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (AML)
Number of subjects: 15
Study 11848168 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan (LOS)
Number of subjects: 15
Study 11848168 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine (AML) and Losartan (LOS)
Number of subjects: 15
Study 10077137 — intervention group
Group type: COMPARATOR
Intervention: Fenoterol (1 puff [200 microg/puff] every 1 min for 5 min; total 1000 microg)
Number of subjects: 69
Study 10077137 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol plus oxitropium bromide (2 puffs [100 microg/puff] every 1 min for 5 min; total 1000 microg)
Number of subjects: 69
Study 10077137 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol plus oxitropium bromide
Number of subjects: 69
Study 7483800 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR vaccine containing the Urabe mumps strain
Number of subjects: 475
Study 7483800 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR vaccine containing the Jeryl Lynn mumps strain
Number of subjects: 475
Study 7483800 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR vaccine containing the Schwarz strain
Number of subjects: 475
Study 7483800 — intervention group
Group type: EXPERIMENTAL
Intervention: MMR vaccine (all types)
Number of subjects: 475
Study 2298472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 2298472 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide, Atenolol, Captopril, Zofenopril
Number of subjects: 51
Study 6113352 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acyclovir
Number of subjects: 24
Study 6113352 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 30981681 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet M - high monounsaturated fat hypocaloric diet
Number of subjects: 361
Study 30981681 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet P - high polyunsaturated fat hypocaloric diet
Number of subjects: 361
Study 31006262 — intervention group
Group type: EXPERIMENTAL
Intervention: Jet-lavage
Number of subjects: 40
Study 31006262 — intervention group
Group type: COMPARATOR
Intervention: Control (no lavage)
Number of subjects: 40
Study 30541641 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume Controlled Ventilation (VCV) with 7 L/min atomized oxygen flow
Number of subjects: 77
Study 30541641 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure Controlled Ventilation (PCV) with 9 L/min atomized oxygen flow
Number of subjects: 77
Study 30541641 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated scuba test under VCV mode with 9 L/min atomized oxygen flow
Number of subjects: 77
Study 30541641 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated scuba test under PCV mode with 9 L/min atomized oxygen flow
Number of subjects: 77
Study 27994300 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Ischaemic Preconditioning (RIPC)
Number of subjects: 100
Study 27994300 — intervention group
Group type: COMPARATOR
Intervention: Control (sham, un-inflated cuff)
Number of subjects: 100
Study 25551178 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic therapy for impetigo
Number of subjects: 508
Study 22726916 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 sets of 30 s postero-anterior mobilisations
Number of subjects: 19
Study 22726916 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 sets of 60 s postero-anterior mobilisations
Number of subjects: 19
Study 22726916 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 sets of postero-anterior mobilisations
Number of subjects: 19
Study 20637445 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge sources
Number of subjects: 0
Study 20637445 — intervention group
Group type: EXPERIMENTAL
Intervention: Analysis domain of the HSRT
Number of subjects: 0
Study 20637445 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasoning skills
Number of subjects: 0
Study 18468899 — intervention group
Group type: EXPERIMENTAL
Intervention: ACL-deficient patients
Number of subjects: 24
Study 18468899 — intervention group
Group type: COMPARATOR
Intervention: Healthy athletes
Number of subjects: 24
Study 16575135 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate 125 mg twice daily along with macrolides (azitromycin for five days)
Number of subjects: 54
Study 16575135 — intervention group
Group type: COMPARATOR
Intervention: Control group treated only with antibiotics (macrolides)
Number of subjects: 54
Study 14645774 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior problem score at age 35 months
Number of subjects: 265
Study 14645774 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior problems in children with asthma
Number of subjects: 265
Study 14645774 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior problems as a marker
Number of subjects: 265
Study 10194656 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril (ACE inhibitor), 12 weeks treatment
Number of subjects: 22
Study 10194656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 8946872 — intervention group
Group type: EXPERIMENTAL
Intervention: 5‐FU chemotherapy via pelvic retroperitoneal cannulation
Number of subjects: 25
Study 1753321 — intervention group
Group type: EXPERIMENTAL
Intervention: Open flap debridement and placement of the synthetic wound dressing over the furcation
Number of subjects: 19
Study 1753321 — intervention group
Group type: COMPARATOR
Intervention: Open flap debridement alone
Number of subjects: 19
Study 6763175 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (Healon)
Number of subjects: 40
Study 6763175 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution or air
Number of subjects: 40
Study 31331575 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhythmical Massage (RM)
Number of subjects: 60
Study 31331575 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate Variability Biofeedback (HRV-BF)
Number of subjects: 60
Study 31331575 — intervention group
Group type: EXPERIMENTAL
Intervention: Both therapies (RM and HRV-BF)
Number of subjects: 60
Study 31331575 — intervention group
Group type: EXPERIMENTAL
Intervention: Body silhouette diagrams
Number of subjects: 60
Study 28183140 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus
Number of subjects: 550
Study 28183140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 550
Study 26452466 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative smoking cessation intervention
Number of subjects: 800
Study 26452466 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 800
Study 23337728 — intervention group
Group type: EXPERIMENTAL
Intervention: Odanacatib 50 mg weekly
Number of subjects: 214
Study 21266948 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 1801
Study 21266948 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 1801
Study 19835115 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate acupuncture group (opposing needling and non-opposing needling, twice daily)
Number of subjects: 80
Study 19835115 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture group (acupuncture at the affected side, once daily)
Number of subjects: 80
Study 19835115 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate acupuncture group
Number of subjects: 80
Study 19835115 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture group
Number of subjects: 80
Study 17386282 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate
Number of subjects: 24
Study 17386282 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 24
Study 17386282 — intervention group
Group type: EXPERIMENTAL
Intervention: Brinzolamide
Number of subjects: 24
Study 15322457 — intervention group
Group type: EXPERIMENTAL
Intervention: PMRP+25
Number of subjects: 10
Study 15322457 — intervention group
Group type: EXPERIMENTAL
Intervention: PMRP+50
Number of subjects: 10
Study 15322457 — intervention group
Group type: EXPERIMENTAL
Intervention: PMRP
Number of subjects: 10
Study 15322457 — intervention group
Group type: COMPARATOR
Intervention: Sitting
Number of subjects: 10
Study 11594943 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose antioxidant formulation (vitamin C, 500 mg; vitamin E, 400 IU; beta carotene, 15 mg)
Number of subjects: 4629
Study 11594943 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no antioxidants)
Number of subjects: 4629
Study 9692520 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg orally once a day for 3 days
Number of subjects: 34
Study 9692520 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin 500 mg orally every 12 h for 10 days
Number of subjects: 34
Study 8164925 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasic DSG/EE
Number of subjects: 812
Study 8164925 — intervention group
Group type: COMPARATOR
Intervention: Triphasic NE/EE
Number of subjects: 812
Study 8164925 — intervention group
Group type: EXPERIMENTAL
Intervention: Triphasic DSG/EE and Triphasic NE/EE
Number of subjects: 812
Study 3211806 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchidectomy (ORX, n = 37)
Number of subjects: 78
Study 3211806 — intervention group
Group type: COMPARATOR
Intervention: Combined intramuscular and oral estrogen treatment (ESTR, n = 41)
Number of subjects: 78
Study 3211806 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (ORX and ESTR)
Number of subjects: 78
Study 3211806 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with metastatic disease
Number of subjects: 78
Study 3211806 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with nonmetastatic disease
Number of subjects: 78
Study 31430623 — intervention group
Group type: EXPERIMENTAL
Intervention: Wi-Fi signal cues in the PIU group
Number of subjects: 60
Study 31430623 — intervention group
Group type: EXPERIMENTAL
Intervention: Wi-Fi signal cues under negative affect priming in the PIU group
Number of subjects: 60
Study 31430623 — intervention group
Group type: COMPARATOR
Intervention: Control group with neutral cues
Number of subjects: 60
Study 29090984 — intervention group
Group type: EXPERIMENTAL
Intervention: Ball attachments (group A)
Number of subjects: 22
Study 29090984 — intervention group
Group type: EXPERIMENTAL
Intervention: Locator attachments (group B)
Number of subjects: 22
Study 26129787 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior mitral isthmus ablation
Number of subjects: 80
Study 26129787 — intervention group
Group type: COMPARATOR
Intervention: Posterior mitral isthmus ablation
Number of subjects: 80
Study 23486236 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic lozenges containing L. reuteri (DSM 17938 and ATCC PTA 5289; 1 × 10(8) CFU of each strain), 2/day
Number of subjects: 62
Study 23486236 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenges lacking lactobacilli
Number of subjects: 62
Study 21636819 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill aerobic exercise training (TM)
Number of subjects: 38
Study 21636819 — intervention group
Group type: COMPARATOR
Intervention: Control intervention of nonaerobic stretching
Number of subjects: 38
Study 18768332 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg qd
Number of subjects: 1024
Study 18768332 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg bid
Number of subjects: 1024
Study 18768332 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 1024
Study 16946431 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser with distilled water irrigation
Number of subjects: 72
Study 16946431 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser with 5.25% NaOCl irrigation
Number of subjects: 72
Study 16946431 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary instrumentation with distilled water irrigation
Number of subjects: 72
Study 16946431 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary instrumentation with 5.25% NaOCl irrigation
Number of subjects: 72
Study 15478759 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Memory (WM)
Number of subjects: 0
Study 15478759 — intervention group
Group type: EXPERIMENTAL
Intervention: Second‐order WM factor
Number of subjects: 0
Study 11306522 — intervention group
Group type: EXPERIMENTAL
Intervention: apoA-I(M) carriers
Number of subjects: 21
Study 11306522 — intervention group
Group type: COMPARATOR
Intervention: Hypoalphalipoproteinemia (HA) subjects
Number of subjects: 21
Study 11306522 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 21
Study 11306522 — intervention group
Group type: COMPARATOR
Intervention: HA subjects
Number of subjects: 21
Study 11306522 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic findings and maximal treadmill ECG
Number of subjects: 21
Study 9141257 — intervention group
Group type: EXPERIMENTAL
Intervention: Sponging alone
Number of subjects: 224
Study 9141257 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 15 mg/kg
Number of subjects: 224
Study 9141257 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 15 mg/kg
Number of subjects: 224
Study 9141257 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 8 mg/kg
Number of subjects: 224
Study 9141257 — intervention group
Group type: COMPARATOR
Intervention: Tepid water sponging
Number of subjects: 224
Study 8186346 — intervention group
Group type: EXPERIMENTAL
Intervention: Tripotassium dicitrato bismuthate one tablet q.d.s
Number of subjects: 14
Study 8186346 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg b.d.
Number of subjects: 14
Study 3035166 — intervention group
Group type: EXPERIMENTAL
Intervention: Salt and peroxide oral hygiene regimen
Number of subjects: 231
Study 3035166 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral hygiene regimen
Number of subjects: 231